Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
Life · 09.06.2023 · 13 (6) · 1362
DOI: 10.3390/life13061362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 09.06.2023. Verfasst von Filippo Confalonieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Antiplatelets and anticoagulants have substantially influenced contemporary vitreoretinal surgical practices. The availability of new oral blood thinners has recently spurred a renewed interest in the clinical approach to vitreoretinal surgical conditions since it may be difficult for the surgeon to collect sufficient evidence-based data to decide whether to discontinue or continue such medications. Materials and Methods: We conducted a systematic review on the use of antiplatelets and/or anticoagulants in the perioperative setting in vitreoretinal surgery and their possible complications, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The level of evidence, according to the Oxford Centre for Evidence-Based Medicine (OCEM) 2011 guidelines, and the quality of evidence, according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system, were assessed for all included articles.
Results
In total, 2310 articles were initially extracted, out of which 1839 articles were obtained after duplicates were removed and their abstracts were screened. A total of 27 articles were included in the full-text review. Finally, a remaining 22 articles fulfilled the inclusion criteria.
Conclusions
Even though there is just a small number of studies with solid results, the advantage of using antiplatelets and/or anticoagulants in vitreoretinal surgery seems to outweigh the disadvantages, which are mainly related to postoperative hemorrhagic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.
- Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute for Clinical Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway.
- Department of Ophthalmology, Oslo University Hospital, Kirkeveien 166, 0450 Oslo, Norway.
- Department of Internal Medicine and Medical Specialties (DIMI), Università di Genova, Viale Benedetto XV, 6, 16132 Genova, Italy.
- Eye Hospital, University Medical Centre Ljubljana, Zaloška Cesta 2, 1000 Ljubljana, Slovenia.
ORCID-Profile: Filippo Confalonieri, Vanessa Ferraro, Alessandra Di Maria, Alessandro Gaeta, Paolo Vinciguerra, Goran Petrovski
Zitieren
APA
Confalonieri, F., Ferraro, V., Di Maria, A., Gaeta, A., Vallejo-Garcia, J. L., Vinciguerra, P., Lumi, X., & Petrovski, G. (2023). Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review. Life, 13(6), 1362. https://doi.org/10.3390/life13061362
Vancouver
Confalonieri F, Ferraro V, Di Maria A, Gaeta A, Vallejo-Garcia JL, Vinciguerra P, et al. Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review. Life. 2023;13(6):1362. doi:10.3390/life13061362
BibTeX
@article{Confalonieri2023,
author = {Confalonieri, Filippo and Ferraro, Vanessa and Di Maria, Alessandra and Gaeta, Alessandro and Vallejo-Garcia, Josè Luis and Vinciguerra, Paolo and Lumi, Xhevat and Petrovski, Goran},
title = {Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review},
journal = {Life},
year = {2023},
volume = {13},
number = {6},
pages = {1362},
doi = {10.3390/life13061362}
}
EUVIMED